TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IBIO

iBio, Inc.

Healthcare · Biotechnology

1.10$ +1.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IBIO
Line item 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
– -5.8% +38.9% 0.0% +48.8% +33.1% -4.2% -30.6% +92.4% +313.0% -30.2% +19.6% -29.0% +207.9% +56.0% -32.4% -58.5% -30.3% -19.3% +327.5%
– -4.5% +653.0% -19.0% +319.3% +60.5% -3.8% -41.0% +158.7% +136.2% -64.1% +90.0% -70.5% +1,184.3% +69.4% -56.9% -41.7% -40.3% -38.0% +848.7%
– +0.9% +5,368.3% -12.4% +212.5% +97.8% -21.5% -18.7% +164.5% +142.4% -64.9% +97.0% -72.3% +1,146.6% +40.4% -70.7% -67.7% +94.0% -39.6% +557.1%
– +0.9% +5,368.3% -12.4% +212.5% +97.8% -21.5% -18.7% +164.5% +142.4% -64.9% +97.0% -72.3% +1,146.6% +76.0% -65.4% -78.1% +94.0% -39.6% +925.9%
– -27.7% +99.0% -77.4% +1,338.5% -13.4% +70.3% -79.6% +117.1% +36.2% -71.1% -57.1% +29.3% +5,697.9% -1.7% +10.4% -96.7% +249.5% -85.3% +951.4%
– – – – – -10.4% +72.8% -90.7% +50.0% -86.7% +18.2% -100.0% – +79,799,900.0% -96.6% +14,344.4% +440.8% – – –
– – – -26.7% -18.2% -72.3% +140.3% +0.0% +116.7% +196,623.1% +0.1% -1.7% -3.1% -85.0% +849.9% +20.2% -81.9% – – –
– – – – – – – – – – – – – – – – – – – –
– +1.3% +8.4% +6.7% -22.3% -5.5% -5.2% -5.1% -8.3% -11.4% -12.9% -11.1% -15.2% -16.7% -16.8% +409.6% +11.1% -0.4% +27.6% -73.3%
– +20.4% -94.4% +610.9% +85.2% -49.6% +19.2% -90.8% +219.7% +2,081.8% -1.7% -0.6% +4.5% +33.6% +2.2% -6.5% -28.1% -71.3% +12.1% +61.3%
– +35.7% -71.9% +610.9% +85.2% -49.6% +19.2% -90.8% +219.7% +81.4% -12.1% +1.1% +69.9% +51.4% +26.9% +358.0% -29.1% -82.2% +59.0% +92.4%
– – – – – – – – – – +7.6% +7.7% +8.1% +163.8% +72.1% +2,201.1% -38.9% -93.0% +37.4% -58.3%
– +43.1% -77.8% +1,686.8% +44.3% -1.7% -15.6% -89.2% +267.2% -28.8% -51.0% +138.0% +26.7% +75.7% +28.1% +89.2% -56.6% -80.6% +511.2% +102.1%
– – – – – – – – – – -0.7% -0.8% – – – – – – – –
– – – -75.5% -81.7% +3,037.2% -17.8% +20.3% +84.1% -11.5% -10.3% +81.4% -84.8% +2,198.7% +91.8% -41.5% -75.8% +38.6% -30.2% +476.0%
– – – – – – – – – – – – – – – – – – – –
– +0.0% -97.8% +34.7% +13.4% +27.6% +25.0% +27.5% +13.5% +13.3% +10.1% +19.3% +78.0% +231.8% +211.5% -95.5% +3,410.2% +525.7% +174.1% +891.1%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?